- Home
- NNOX vs PRQR Comparison
NNOX vs PRQR Comparison
Compare NNOX & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNOX
- PRQR
- Stock Information
- Founded
- NNOX 2011
- PRQR 2012
- Country
- NNOX Israel
- PRQR Netherlands
- Employees
- NNOX N/A
- PRQR N/A
- Industry
- NNOX Medical Electronics
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- NNOX Health Care
- PRQR Health Care
- Exchange
- NNOX Nasdaq
- PRQR Nasdaq
- Market Cap
- NNOX 253.8M
- PRQR 224.4M
- IPO Year
- NNOX 2020
- PRQR 2014
- Fundamental
- Price
- NNOX $3.73
- PRQR $2.65
- Analyst Decision
- NNOX Strong Buy
- PRQR Strong Buy
- Analyst Count
- NNOX 2
- PRQR 8
- Target Price
- NNOX $8.50
- PRQR $8.88
- AVG Volume (30 Days)
- NNOX 1.3M
- PRQR 637.0K
- Earning Date
- NNOX 11-20-2025
- PRQR 11-07-2025
- Dividend Yield
- NNOX N/A
- PRQR N/A
- EPS Growth
- NNOX N/A
- PRQR N/A
- EPS
- NNOX N/A
- PRQR N/A
- Revenue
- NNOX $11,886,000.00
- PRQR $20,129,184.00
- Revenue This Year
- NNOX $20.50
- PRQR N/A
- Revenue Next Year
- NNOX $64.10
- PRQR N/A
- P/E Ratio
- NNOX N/A
- PRQR N/A
- Revenue Growth
- NNOX 17.36
- PRQR 8.65
- 52 Week Low
- NNOX $3.60
- PRQR $1.07
- 52 Week High
- NNOX $11.00
- PRQR $4.21
- Technical
- Relative Strength Index (RSI)
- NNOX 41.38
- PRQR 52.63
- Support Level
- NNOX $3.86
- PRQR $2.61
- Resistance Level
- NNOX $4.17
- PRQR $3.00
- Average True Range (ATR)
- NNOX 0.21
- PRQR 0.24
- MACD
- NNOX -0.04
- PRQR -0.02
- Stochastic Oscillator
- NNOX 3.85
- PRQR 50.00
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.